<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Research in Applied and Basic Medical Sciences</title>
<title_fa></title_fa>
<short_title>Journal of Research in Applied and Basic Medical Sciences</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijrabms.umsu.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn></journal_id_issn>
<journal_id_issn_online>2717-0098</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.61882/rabms</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1400</year>
	<month>9</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2021</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<volume>7</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa>Evaluation of Celecoxib-Lactose Incompatibility Reactions at Solid State using Physicochemical Methods</title_fa>
	<title>Evaluation of Celecoxib-Lactose Incompatibility Reactions at Solid State using Physicochemical Methods</title>
	<subject_fa>تخصصي</subject_fa>
	<subject>Special</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>orginal article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;strong&gt;&lt;em&gt;Background &amp; Aims&lt;/em&gt;&lt;/strong&gt;: &amp;nbsp;Drug excipient incompatibility evaluation is an important part of pre-formulation studies. Drug-excipient interaction may affect drug stability, bioavailability, therapeutic effects, efficacy, and safety. Therefore, development of a successful drug delivery systems or dosage forms depends on correct selection of excipients. The aim of this study is to evaluate of celecoxib-lactose incompatibility reactions at solid state using physicochemical methods.&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Materials &amp; Methods:&lt;/em&gt;&lt;/strong&gt; Celecoxib and lactose were blended in 1:1 mass ratios and added to 20% (v/w) water and stored in closed vials at 60&amp;deg;C (inside the oven). Also, pure drug and pure excipient were prepared. Celecoxib, celecoxib-lactose and lactose tablets prepared using direct compression method. Produced tablets were stored at 60 &amp;deg;C (inside the oven). Finally, celecoxib -lactose incompatibility in the solid state was investigated by Fourier transform infrared (FTIR) and differential scanning calorimetry (DSC) methods over four consecutive weeks.&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Results&lt;/em&gt;&lt;/strong&gt;&lt;strong&gt;:&lt;/strong&gt; the incompatibility of celecoxib with lactose was not observed using physicochemical methods including DSC, FTIR spectroscopy and also visual observation.&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Conclusion:&lt;/em&gt;&lt;/strong&gt; It can be concluded that using lactose in celecoxib solid pharmaceutical preparations will not cause incompatibilities.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Incompatibility, Excipient, Celecoxib, Lactose</keyword>
	<start_page>139</start_page>
	<end_page>146</end_page>
	<web_url>http://ijrabms.umsu.ac.ir/browse.php?a_code=A-10-90-2&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Ali</first_name>
	<middle_name></middle_name>
	<last_name>Fattahzadeh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ali.fattahzadeh247@gmail.com</email>
	<code>10031947532846001239</code>
	<orcid>10031947532846001239</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>School of pharmacy, Urmia University of Medical Sciences, Urmia, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Azin</first_name>
	<middle_name></middle_name>
	<last_name>Jahangiri</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>jahangiri.az@gmail.com</email>
	<code>10031947532846001240</code>
	<orcid>10031947532846001240</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of pharmaceutics, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Naser</first_name>
	<middle_name></middle_name>
	<last_name>Ranjkeshzadeh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>n.ranjkeshzadeh@yahoo.cim</email>
	<code>10031947532846001241</code>
	<orcid>10031947532846001241</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>School of pharmacy, Urmia University of Medical Sciences, Urmia, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Faranak</first_name>
	<middle_name></middle_name>
	<last_name>Ghaderi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>f.ghaderi1390@gmail.com</email>
	<code>10031947532846001242</code>
	<orcid>10031947532846001242</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Pharmaceutical and Food Control, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran,research center for experimental and applied pharmaceutical Sciences</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
